Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
European Journal of Gynaecological Oncology|January 1, 1997
Intraperitoneal cisplatin--mitoxantrone in ovarian cancer patients with minimal residual diseaseE Topuz, A Aydiner, P Saip, et al.European Journal of Gynaecological Oncology|March 5, 2002
The role of chemotherapy in malignant mixed mullerian tumors of the female genital tractE Topuz, Y Eralp, A Aydiner, et al.European Journal of Gynaecological Oncology|February 24, 2001
Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancerE Topuz, A Aydiner, P Saip, et al.American Journal of Clinical Oncology|February 24, 2001
Angiogenesis and p53 protein expression in breast cancer: prognostic roles and interrelationshipsF Tas, E Yavuz, A Aydiner, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2003
Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervixY Eralp, P Saip, B Sakar, et al.European Journal of Gynaecological Oncology|March 10, 2005
Value of glutathion-S transferase pi as a prognostic factor in epithelial ovarian carcinomaP Saip, S Tuzlali, K Demir, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 6, 2006
The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 diseaseG Aksu, S Kucucuk, M Fayda, et al.Journal of Surgical Oncology|August 22, 2000
Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancerE Topuz, Y Salihoglu, A Aydiner, et al.Cancer Investigation|December 11, 1999
Response evaluation of bone metastases in breast cancer: value of magnetic resonance imagingP Saip, N Tenekeci, A Aydiner, et al.European Journal of Gynaecological Oncology|April 26, 2001
The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinomaE Topuz, Y Eralp, P Saip, et al.Pageof 3